Table 1.
Attribute | Sources examined (#) |
---|---|
Publication (year)a | 54 |
• < 2012 | • 7 |
• ≥ 2012 | • 45 |
• No yearb | • 2 |
Definition of ELL | 54 |
• ≤ 3 μg/dL | • 1 |
• ≤ 5 μg/dL | • 43 |
• ≤ 10 μg/dL | • 10 |
Screeningc | 54 |
• Targeted | • 35 |
• Universal | • 18 |
• Not Addressed | • 1 |
Reporting (for states and District of Columbia only) | 51 |
• Mandated All Results | • 43 |
• Mandated ELL Only | • 7 |
• Undefined | • 1 |
Clinical Management | 54 |
• Provides Management Guidance | • 43 |
• No Management Guidance | • 11 |
Follow Up | 54 |
• Provides Follow Up Guidance | • 40 |
• No Follow Up Guidance | • 14 |
aThe AAP published a revised ELL in 2012, which we used as a cutoff for source evaluation
bMissouri and Nevada guidance sources lacked publication dates, but documents referenced in these sources indicate these policies were updated or reviewed during or after 2011 for Missouri and circa 2008 for Nevada
cDoes not include NY city guidance as it does not differ from NY state guidance